During the week of June 15, 2026, FDA issued 25 warning letters to telehealth companies over alleged false or misleading promotional claims about compounded GLP-1 productsclaims the agency views as violating the Federal Food, Drug, and Cosmetic Acts (FDCA) misbranding provisions, including Sections 502(a) and 502(n)
This pricing structure limits access to patients with robust insurance benefits or substantial out-of-pocket budgets, leaving many who could benefit from GLP-1 therapy unable to afford treatment
b Novo Nordisk defines formulary coverage as Preferred, Covered, or Covered with Restrictions
Intestinal Blockage (Ileus/Bowel Obstruction): This occurs when there is a mechanical or non-mechanical obstruction that prevents food and waste from passing through the intestines
Unlike other carbs that are broken down into sugar, fiber moves through the digestive tract relatively intact, doing essential behind-the-scenes work
Some researchers ask if adding BAC water to oral peptide solutions extends shelf life the way it does in injectable formulations
